How GeneDx Holdings makes money

Period

FY2025

How does GeneDx Holdings make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

GeneDx Holdings Corp. · FY2025 · year ended 2025-12-31

Revenue$428MNet loss$21M · 5%Cost of revenue$129M · 30%Gross profit$298M · 70%Operating expenses$311M · 73%R&D$72M · 17%SG&A$151M · 35%Selling & marketing$88M · 21%Other expense$8M · 2%Diagnostic Test Third Party Insurance$345M · 81%Diagnostic Test Institutional Customers$70M · 16%Product & Service Other$11M · 3%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.